Five doses of anti-Lair1 antibody (200 μg/dose) were administered after tumor establishment followed by 5 doses of anti-Lair1 antibody (200ug/dose) and 1 dose of mouse CD70CAR T cells (Figure 4I). The gene discussed is LAIR1; the disease is neoplasm.